Ikonisys S.A. announced that the publication of its 2023 annual financial report will be further postponed and will be published by June 28, 2024. As announced on April 29, 2024, due to the internal reorganization following the acquisition of Hospitex, the Company experienced a technical delay in the finalization of its audited consolidated financial statements. The management expects to publish the audited 2023 Annual Financial Report by June 28, 2024.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 EUR | -1.39% |
|
-1.39% | -8.97% |
13/06 | Ulisse Biomed and Ikonisys together to innovate oncology diagnostics | AN |
12/06 | Ikonisys, Ulisse Biomed to Collaborate on New Cancer Diagnostic Technologies | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.97% | 16.25M | |
-10.44% | 11.48B | |
-9.80% | 7.64B | |
+3.13% | 5.58B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-11.76% | 2.27B | |
+21.21% | 2.1B |
- Stock Market
- Equities
- ALIKO Stock
- News Ikonisys S.A.
- Ikonisys S.A. Announces Postponement of the Publication of its 2023 Annual Financial Report